|
Neuroprotectors
Citations 231-240 of 537 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Proof-of-Principle Phase II MRI Studies in Stroke. Sample Size Estimates From Dichotomous and Continuous Data
- Thanh G. Phan, Geoffrey A. Donnan, Stephen M. Davis, Graham Byrnes on behalf of the MR Stroke Collaborative Group
Stroke published August 24, 2006, doi:10.1161/01.STR.0000239696.61545.4b
[Abstract]
- Original Contributions
The ALIAS Pilot Trial: A Dose-Escalation and Safety Study of Albumin Therapy for Acute Ischemic Stroke—I: Physiological Responses and Safety Results
- Myron D. Ginsberg, Michael D. Hill, Yuko Y. Palesch, Karla J. Ryckborst, and Diego Tamariz
Stroke 2006;37:2100-2106; published online before print as doi:10.1161/01.STR.0000231388.72646.05
[Abstract]
[Full text]
- Original Contributions
The ALIAS Pilot Trial: A Dose-Escalation and Safety Study of Albumin Therapy for Acute Ischemic Stroke—II: Neurologic Outcome and Efficacy Analysis
- Yuko Y. Palesch, Michael D. Hill, Karla J. Ryckborst, Diego Tamariz, and Myron D. Ginsberg
Stroke 2006;37:2107-2114; published online before print as doi:10.1161/01.STR.0000231389.34701.b5
[Abstract]
[Full text]
- Cochrane Corner
Piracetam for Acute Ischemic Stroke
- Graeme J. Hankey, Stefano Ricci, Maria Grazia Celani, Teresa Anna Cantisani, and Enrico Righetti
Stroke 2006;37:2191-2192; published online before print as doi:10.1161/01.STR.0000231643.42650.a9
[Full text]
- Original Contributions
Intrinsic Activated Microglia Map to the Peri-infarct Zone in the Subacute Phase of Ischemic Stroke
- Christopher J.S. Price, Dechao Wang, David K. Menon, Joe V. Guadagno, Marcel Cleij, Tim Fryer, Franklin Aigbirhio, Jean-Claude Baron, and Elizabeth A. Warburton
Stroke 2006;37:1749-1753; published online before print as doi:10.1161/01.STR.0000226980.95389.0b
[Abstract]
[Full text]
- Original Contributions
Vasospasm and p53-Induced Apoptosis in an Experimental Model of Subarachnoid Hemorrhage
- Julian Cahill, John W. Calvert, Ihsan Solaroglu, and John H. Zhang
Stroke 2006;37:1868-1874; published online before print as doi:10.1161/01.STR.0000226995.27230.96
[Abstract]
[Full text]
- Original Contributions
Cathepsin and Calpain Inhibitor E64d Attenuates Matrix Metalloproteinase-9 Activity After Focal Cerebral Ischemia in Rats
- Tamiji Tsubokawa, Ihsan Solaroglu, Hiroshi Yatsushige, Julian Cahill, Kenichiro Yata, and John H. Zhang
Stroke 2006;37:1888-1894; published online before print as doi:10.1161/01.STR.0000227259.15506.24
[Abstract]
[Full text]
- Original Contributions
Inhibition of Integrin  vß3 Ameliorates Focal Cerebral Ischemic Damage in the Rat Middle Cerebral Artery Occlusion Model
- Norihito Shimamura, Gerald Matchett, Hiroshi Yatsushige, John W. Calvert, Hiroki Ohkuma, and John Zhang
Stroke 2006;37:1902-1909; published online before print as doi:10.1161/01.STR.0000226991.27540.f2
[Abstract]
[Full text]
- Research Reports
Reduction of Tissue Plasminogen Activator-Induced Matrix Metalloproteinase-9 by Simvastatin in Astrocytes
- Sophia Wang, Sun-Ryung Lee, Shu-Zhen Guo, Woo Jean Kim, Joan Montaner, Xiaoying Wang, and Eng H. Lo
Stroke 2006;37:1910-1912; published online before print as doi:10.1161/01.STR.0000226923.48905.39
[Abstract]
[Full text]
- Articles
The ALIAS Pilot Trial. A Dose-Escalation and Safety Study of Albumin Therapy for Acute Ischemic Stroke--II: Neurologic Outcome and Efficacy Analysis
- Yuko Y. Palesch, Michael D. Hill, Karla J. Ryckborst, Diego Tamariz, and Myron D. Ginsberg
Stroke published June 29, 2006, doi:10.1161/01.STR.0000231389.34701.b5
[Abstract]
|
|
